Key points are not available for this paper at this time.
experiments show that ZIF-8 NCs exhibit high tumor inhibition efficiency (84.6%) as both a bioactive anticancer agent and a sonosensitizer. We believe that this study can expand the application of MOFs and contribute to a better understanding of the mechanism of action of sonosensitizers.
Wang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: